Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Altimmune, Inc.

NASDAQ: ALTHealthcare / Biotechnology / -
2.91-0.1900-6.13%Vol 259 2601Y Perf -94.80%
Jan 18th, 2019 16:00
BID2.91 ASK2.94
Open3.08 Previous Close3.10
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.00 
Analyst Rating
Strong Buy 1.00
Potencial %
243.64 
Finscreener Ranking
★★★★★     64.04
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
★★★+     55.39
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★+     48.78
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)25 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.13 
Earnings Date
15th Nov 2018

Today's Price Range

2.873.09

 

52wk Range

1.7058.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
39.90%
3 Months
-32.48%
6 Months
-73.06%
1 Year
-94.80%
3 Years
-94.81%
5 Years
-95.79%

Quotes

Name / TickerPriceChg.Chg.%
ALT2.91-0.1900-6.13
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.40
Current Ratio
1.40
Long Term Debt to Total Capital
0.01
Total Debt to Equity
0.05
Interest Coverage
-173.20
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-282.00
EBITDA Margin
-279.80
Pre-tax Profit Margin
564.30
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
0.00
PB Ratio
0.59
PS Ratios
3.03
Price to Cash Flow
0.10
Price to Free Cash Flow
-4.50
Cash Flow Per Share
-10.33
Price to Tangible Book
17.46
Book Value per Share
4.53
Enterprise Value (in ths.)
17 512
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
117.83
ROE last 12 Months
-65.14
Return on Assets (5Y Avg)
37.05
ROA last 12 Months
-45.32
Return on Capital (5Y Avg)
128.65
ROC last 12 Months
-63.13
Return on invested Capital Q
-5.47
Return on invested Capital Y
-170.41
Assets Turnover
0.10
Receivables Turnover
0.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
7 743
Revenue per Share
0.88
Revenue Growth 3 Years
-3.39
Revenue Growth 5 Years
-13.18
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-3.60-1.7351.94
Q02 2018-4.50-4.80-6.67
Q01 2018-15.02-6.9153.99
Q04 2017-15.02-3.6076.03
Q03 2017-6.91-10.21-47.76
Q04 2016-11.80-
Q02 2016-1.20-
Q01 2016--0.02-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-2.800.00-
12/2018 QR-2.8037.78Positive
12/2018 FY-21.870.00-
12/2019 FY-2.060.00-
Next Report Date-
Estimated EPS Next Report-3.60
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume259 260
Shares Outstanding (in ths.)8 755
Trades Count767
Dollar Volume736 592
Avg. Volume486 741
Avg. Weekly Volume752 746
Avg. Monthly Volume412 401
Avg. Quarterly Volume496 757

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

38%62%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News